文献速递头颈外科

诱导化疗后放疗治疗N3期头颈部鳞状细胞癌

Induction chemotherapy followed by radiotherapy for N3 head and neck squamous cell carcinoma.
PubMed 文献 · Head Neck · 2019-12-04

回顾性分析120例接受诱导化疗作为初始治疗的N3期(≥6 cm)头颈部鳞状细胞癌患者,诱导化疗反应率68.3%。反应者与非反应者的5年总生存率(35.1% vs 13.3%,P < .001)和无进展生存率(29.4% vs 7.4%,P < .001)差异有统计学意义。良好反应(P < .001)和放疗前前期颈部清扫(P = .016)是更好总生存的预测因素,但反应者中放疗前前期颈部清扫与结局改善无关。

要点

  • 诱导化疗可用于N3期头颈部鳞癌,反应率68.3%。
  • 诱导化疗反应者5年OS和PFS显著优于非反应者。
  • 反应者中放疗前前期颈部清扫可能可避免。

核心结论

  • 诱导化疗可能是N3期头颈部鳞状细胞癌的一种治疗选择。
  • 诱导化疗反应者中,放疗前前期颈部清扫可避免。

研究设计与样本

  • 回顾性研究,纳入120例N3期(≥6 cm)头颈部鳞状细胞癌患者,均接受诱导化疗作为初始治疗。

主要发现

  • 诱导化疗反应率为68.3%。
  • 反应者与非反应者5年总生存率分别为35.1%和13.3%(P < .001)。
  • 反应者与非反应者5年无进展生存率分别为29.4%和7.4%(P < .001)。
  • 良好反应(P < .001)和放疗前前期颈部清扫(P = .016)是更好总生存的预测因素。
  • 反应者中放疗前前期颈部清扫与结局改善无关。

临床怎么用

  • 对N3期头颈部鳞癌可考虑诱导化疗后放疗。
  • 诱导化疗反应者放疗前可避免前期颈部清扫。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The treatment outcomes for N3 HNSCC treated with induction chemotherapy (ICT) followed by definitive radiation were reported to clarify the role of ICT and potential prognostic factors. METHODS: A retrospective study was conducted on 120 patients with N3 (≥6 cm) HNSCC, who were treated with ICT as initial treatment. Survival outcomes and potential prognostic factors were reported. RESULTS: The response rate to ICT was 68.3%. There was a statistically significant difference between responders and non-responders in terms of 5-year OS (35.1% vs 13.3%, P < .001) and PFS (29.4% vs 7.4%, P < .001). Good response to ICT (P < .001) and upfront neck dissection (UFND) before radiotherapy (P = .016) were factors predicting for better OS. However, UFND before radiotherapy was not associated with improved outcomes among responders. CONCLUSIONS: This study suggests that ICT could be one treatment option for N3 HNSCC. Among responders to ICT, UFND before radiotherapy could be avoided.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Du C, Blanchard P, Even C, et al. Induction chemotherapy followed by radiotherapy for N3 head and neck squamous cell carcinoma. Head Neck. 2019. PMID: 31800157. doi:10.1002/hed.26021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。